A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 4, 2012, Pages 565-572

  Manns, Braden ^a,b   Tonelli, Marcello ^b,c   Culleton, Bruce ^b   Faris, Peter ^a   McLaughlin, Kevin ^a,b   Chin, Rick ^a,b   Gooch, Katherine ^b   McAlister, Finlay A ^b,c   Taub, Ken ^a,b   Thorlacius, Laurel ^b   Krause, Richard ^d   Kearns, Monica ^e   Hemmelgarn, Brenda ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Alberta Kidney Disease Network   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d CALGARY LABORATORY SERVICES   (Canada)

^e ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEINURIA; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBERTA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CHRONIC DISEASE; CLUSTER ANALYSIS; CREATININE; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETIC NEPHROPATHIES; DRUG PRESCRIPTIONS; GLOMERULAR FILTRATION RATE; GUIDELINE ADHERENCE; HUMANS; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; REMINDER SYSTEMS; TIME FACTORS;

EID: 84859542170     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12391211     Document Type: Article

References (39)

1. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
3. James MT, Hemmelgarn BR, Wiebe N, Pannu N, Manns BJ, Klarenbach SW, Tonelli M; Alberta Kidney Disease Network: Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: A cohort study. Lancet 376: 2096-2103, 2010
4. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta KidneyDiseaseNetwork: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
5. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. AmJKidneyDis 37: 484-489, 2001
6. Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA: Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant 17: 1426-1433, 2002
7. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562, 2002
8. Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC: Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 112: 171-178, 2005
9. Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M: Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110: 1557-1563, 2004
10. Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G: Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol 16: 3748-3754, 2005
11. Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC: Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 329: 828, 2004
12. Giatras I, Lau J, Levey AS; Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group: Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials. Ann Intern Med 127: 337-345, 1997
13. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135: 73-87, 2001
14. Grol R, GrimshawJ: Frombest evidence to best practice: Effective implementation of change in patients' care. Lancet 362: 1225-1230, 2003
15. Majumdar SR, McAlister FA, Furberg CD: From knowledge to practice in chronic cardiovascular disease: A long and winding road. J Am Coll Cardiol 43: 1738-1742, 2004
16. Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, Garg AX, Jain AK: Impact of estimated GFR reporting on patients, clinicians, and health-care systems: A systematic review. Am J Kidney Dis 57: 592-601, 2011
17. Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, Klarenbach SW, Culleton BF, Krause R, Thorlacius L, Jain AK, Tonelli M; Alberta KidneyDisease Network: Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA 303: 1151-1158, 2010
18. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559, 2011
19. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D: Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305: 1545-1552, 2011
20. Tonelli M, Manns B: Supplementing creatinine-based estimates of risk in chronic kidney disease: Is it time? JAMA 305: 1593-1595, 2011
21. Shojania KG, Jennings A, Mayhew A, Ramsay C, Eccles M, Grimshaw J: Effect of point-of-care computer reminders on physician behaviour: A systematic review. CMAJ 182: E216-E225, 2010
22. McAlister FA, Fradette M, Majumdar SR, Williams R, Graham M, McMeekin J, Ghali WA, Tsuyuki RT, Knudtson ML, Grimshaw J: The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ 181: 897-904, 2009
23. Thomas RE, Croal BL, Ramsay C, Eccles M, Grimshaw J: Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: A cluster randomised trial. Lancet 367: 1990-1996, 2006
24. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the Alberta Kidney Disease Network. BMC Nephrol 10: 30, 2009
25. Kidney Disease Outcomes Quality Initiative (K/DOQI): K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43[Suppl 1]: S1-S290, 2004
26. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M; Canadian Society of Nephrology: Guidelines for the management of chronic kidney disease. CMAJ 179: 1154-1162, 2008
27. Quan H, Khan N, Hemmelgarn BR, Tu K, Chen G, Campbell N, Hill MD, GhaliWA, McAlister FA; Hypertension Outcome and Surveillance Team of the Canadian Hypertension Education Programs: Validation of a case definition to define hypertension using administrative data. Hypertension 54: 1423-1428, 2009
28. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512-516, 2002
29. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130-1139, 2005
30. Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research, edited by Donner A, Klar N, London, England, Arnold, 2000
31. Campbell MK, Elbourne DR, Altman DG; CONSORT group: CONSORT statement: Extension to cluster randomised trials. BMJ 328: 702-708, 2004
32. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22, 1986
33. Rabe-Hesketh S, Skrondal A: Multilevel and Longitudinal Modeling Using Stata, College Station, TX, Stata Press, 2007
34. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB: Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA 293: 1223-1238, 2005
35. Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Improving clinical practice using clinical decision support systems: A systematic reviewof trials to identify features critical to success. BMJ 330: 765, 2005
36. Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russell AS, Hanley DA, Morrish DW, Maksymowych WP, Rowe BH: Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: A randomized controlled trial. CMAJ 178: 569-575, 2008
37. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT; SCRIP-HTN Investigators: A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 168: 2355-2361, 2008
38. DesRoches CM, Campbell EG, Rao SR, Donelan K, Ferris TG, Jha A, Kaushal R, Levy DE, Rosenbaum S, Shields AE, Blumenthal D: Electronic health records in ambulatory care-a national survey of physicians. N Engl J Med 359: 50-60, 2008
39. Balas EA, Weingarten S, Garb CT, Blumenthal D, Boren SA, Brown GD: Improving preventive care by prompting physicians. Arch Intern Med 160: 301-308, 2000